ROSENBERG MORRIS 4
4 · SEATTLE GENETICS INC /WA · Filed Jun 8, 2012
Insider Transaction Report
Form 4
ROSENBERG MORRIS
EVP, Development
Transactions
- Exercise/Conversion
Common Stock
2012-06-07$10.29/sh+13,566$139,594→ 31,209 total - Sale
Common Stock
2012-06-07$22.50/sh−13,566$305,235→ 17,643 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-06-07−13,566→ 0 totalExercise: $10.29Exp: 2017-08-28→ Common Stock (13,566 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Rosenberg on March 15, 2012.
- [F2]Amount of securities beneficially owned following reported transactions includes 17,643 Restricted Stock Units subject to vesting.
- [F3]Shares shall vest at a rate of 25% on 8/28/08 and monthly thereafter until all the shares are fully vested on 8/28/11.